Keyphrases
Airway Inflammation
22%
Airway Obstruction
11%
Allergen
25%
Allergic Asthma
36%
Allergic Diseases
62%
Allergic Rhinitis
54%
Allergy Immunotherapy
18%
Anti-leukotriene Therapy
8%
Antihistamines
12%
Asthma
89%
Asthma Endotypes
12%
Asthma Treatment
18%
Atopy
9%
Bronchial Hyperresponsiveness
9%
Clinical Trials
14%
Design Rationale
8%
Eosinophilic Asthma
18%
Future Therapies
16%
H3 Receptor Antagonist
8%
Heterogeneous Disorder
8%
Human Trials
13%
Immunoglobulin E
17%
Immunomodulator
34%
Inhaled Corticosteroids
12%
Interleukin-4 (IL-4)
11%
Lessons Learned
8%
Lung Function
10%
Nasal
10%
Nasal Allergen Challenge
11%
New Therapies
11%
Omalizumab
37%
Parallel Trials
8%
Pediatric
13%
Placebo-controlled
9%
Ragweed
10%
Randomized Controlled Trial
8%
Randomized Double-blind
10%
Receptor Agonist
10%
Rhinitis Symptoms
8%
Rhinorrhea
10%
Skin Test
17%
Sneezing
8%
Sublingual Immunotherapy
61%
Toll-like
15%
Transcription Factor
9%
United States
18%
Urban children
10%
Viral-induced Wheezing
8%
Virus
10%
Vitamin D Supplementation
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
6%
Airway Obstruction
5%
Allergen
33%
Allergic Asthma
21%
Allergic Rhinitis
33%
Alternative Complement Pathway C3 C5 Convertase
5%
Antihistaminic Agent
16%
Antileukotriene Agent
8%
Asthma
100%
Cannabis
8%
Cannabis Sativa
8%
Clinical Trial
18%
Cytokine
13%
Cytokine Receptor Antagonist
5%
Diseases
74%
Fexofenadine
8%
Group Trial
8%
Histamine H3 Receptor Antagonist
8%
Imiquimod
8%
Immunoglobulin Antibody
8%
Immunoglobulin E
35%
Immunomodulating Agent
26%
Immunomodulation
8%
Immunotherapy
37%
Mepolizumab
8%
Monoclonal Antibody
6%
Nitrite
8%
Nuclear Factor
5%
Oligodeoxynucleotide
5%
Omalizumab
29%
Peroxisome Proliferator Activated Receptor
5%
Placebo
14%
Protein Kinase Syk
5%
Respiratory Tract Disease
10%
Respiratory Tract Inflammation
14%
Rhinorrhea
8%
Toll Like Receptor Agonist
6%
Transcription Factors
6%
Vitamin D
10%
Wheezing
10%
Immunology and Microbiology
Agonist
18%
Airway
13%
Allergen
37%
Allergen Immunotherapy
31%
Allergen Specific Immunotherapy
5%
Allergic Asthma
28%
Allergic Rhinitis
41%
Anaphylaxis
5%
Asthma
92%
Blattella germanica
8%
Cannabis Sativa
8%
Complement Factor B
6%
Cytokine
11%
Cytokine Receptor
6%
Eosinophil
6%
Fexofenadine
8%
Hypersensitivity
5%
Imiquimod
8%
Immune Response
7%
Immunoglobulin Antibody
9%
Immunoglobulin E
31%
Immunomodulating Drugs
29%
Immunotherapy
66%
Leukocyte Count
5%
Leukotriene
8%
Maintenance Drug Dose
5%
Mepolizumab
8%
Monoclonal Antibody
6%
Omalizumab
22%
Peroxisome
6%
Prevalence
5%
Ragweed
12%
Respiratory System
5%
Sneezing
5%
Toll-Like Receptor
13%
Transcription Factors
6%
Virus
8%
